Enzyme Preparations. The basic procedures for growing cells of E. coli (Crookes strain) and for purification and resolution of the pyruvate dehydrogenase complex were carried out as described (1, 4 
The Escherichia colh (Crookes strain) pyruvate dehydrogenase complex [EC 1.2.4.1; pyruvate:lipoate oxidoreductase (decarboxylating and acceptor-acetylating)] has been separated into three enzymes-pyruvate dehydrogenase, dihydrolipoyl transacetylase, and dihydrolipoyl dehydrogenase (1) . These three enzymes, acting in sequence, catalyze overall Reaction 1. The pyruvate dehydrogenase and the dihy-CH3COCO2H + CoA-SH + NAD+ CH:CO-S-CoA + CO2 + NADH + H+ [1] drolipoyl dehydrogenase (a flavoprotein) are joined to the transacetylase by noncovalent bonds. The appearance of the transacetylase in the electron microscope is that of a cube, and its design appears to be based on octahedral (432) symmetry (2, 3) . It consists of 24 apparently identical polypeptide chains of molecular weight 65,000 to 70,000 (4) . Each chain apparently contains one molecule of covalently bound lipoic acid. The molecular weight of pyruvate dehydrogenase isolated from the complex is about 192,000, and it consists of two apparently identical polypeptide chains. The isolated flavoprotein contains two apparently identical polypeptide chains and two molecules of flavin adenine dinucleotide per molecule of enzyme of molecular weight about 112,000. Our data (4) show that the native pyruvate dehy- K-12 pyruvate dehydrogenase complex. It is apparent from our data that the E. coli pyruvate dehydrogenase complex does not contain equimolar amounts of its component enzymes. The present investigation was undertaken to determine the molecular basis of this phenomenon and its functional significance.
MATERIALS AND METHODS
Enzyme Preparations. The basic procedures for growing cells of E. coli (Crookes strain) and for purification and resolution of the pyruvate dehydrogenase complex were carried out as described (1, 4 (12, 13 ). Since we found previously (14) that dihydrolipoyl transsuccinylase, the core enzyme of the a-ketoglutarate dehydrogenase complex, also binds about 18 flavoprotein dimers, the binding sites for flavoprotein on the transacetylase and on the transsuccinylase are likely to be very similar, if not identical. Binding Stoichiometry Determined with Radioactive Enzymes in Conjunction with Gel Filtration Chromatography. Mixtures containing "4C-labeled transacetylase and 3H-labeled pyruvate dehydrogenase in a molar ratio of 1:36 and 14C-labeled transacetylase and 3H-labeled flavoprotein in a molar ratio of 1:48 were chromatographed on columns of Sepharose 6B. The elution profiles are shown in Fig. 1 . The subcomplexes emerged within 30 mit after application of the samples to the columns. From the radioactivity of the peak fractions and the known specific activities of the individual enzymes, we calculate that a molecule of the transacetylase bound about 22 pyruvate dehydrogenase dimers in the absence of flavoprotein and about 21 flavoprotein dimers in the absence of pyruvate dehydrogenase.
Inhibition of Binding of Pyruvate Dehydrogenase to Transacetylase by Bound Flavoprotein. A mixture containing MS-Slabeled transacetylase and 3H-labeled flavoprotein in a molar ratio of 1:24 was incubated for 20 min at 23". The binding stoichiometry, determined by chromatography on Sepharose 6B, showed that about 18.5 flavoprotein dimers were bound per molecule of transacetylase. Pyruvate dehydrogenase was added to the incubation mixture at a molar ratio to transacetylase of 13:1, and the rate of appearance of NAD reduction activity (15) was followed. At 2 min the specific activity of the mixture was 4.6 MAmol of NADH produced/min per mg of transacetylase, and at 3 hr, the specific activity was 34.8. By comparison, the specific activity of the native pyruvate dehydrogenase complex is 95-100,umol of NADH/min per mg of transacetylase (equivalent to 34-37 Amol of NADH/min per mg of complex). In a parallel experiment, MS-labeled transacetylase and 3H-labeled flavoprotein in a molar ratio of 1:7 were incubated for 20 min at 230, and then pyruvate dehydrogenase was added at a molar ratio to transacetylase of 13:1. At 2 min the specific activity of this mixture was 100. The simplest interpretation of these results is that binding of flavoprotein in "excess" of about six flavoprotein dimers per molecule of transacetylase inhibits binding of pyruvate dehydrogenase to the transacetylase. That binding of pyruvate dehydrogenase to the transacetylase-flavoprotein subcomplex and concomitant appearance of NAD reduction activity involves displacement of "excess" flavoprotein was indicated by the results of a second set of experiments. 35S-Labeled transacetylase Biochemistry: Reed et Table 1 show that crosslinking the two polypeptide chains comprising the isolated flavoprotein does not affect the binding of the flavoprotein to the transacetylase. Since overall Reaction 1 apparently involves a coordinated sequence of reactions between protein-bound intermediates, reconstitution of the NADlinked oxidation of pyruvate provides a sensitive test of the functional identity of the crosslinked and native flavoproteins. The results obtained by titrating the transacetylasepyruvate dehydrogenase subcomplex with crosslinked flavoprotein (Fig. 2, Curve 3 ) are similar to those obtained with the native flavoprotein (Curve 1). The differences can be attributed to the somewhat less than optimal molar ratio of transacetylase to pyruvate dehydrogenase used in the experiment with crosslinked flavoprotein and to the fact that the purity of the latter preparation was only about 86%. These observations indicate that flavoprotein monomers are not essential for pyruvate dehydrogenase complex activity and that flavoprotein dimers per se are present in the native complex.
DISCUSSION
The data reported in this communication show that the isolated transacetylase can bind about 22 pyruvate dehydrogenase dimers in the absence of the flavoprotein and 19 to 21 flavoprotein dimers in the absence of pyruvate dehydrogenase. Since in all experiments the binding was measured after separation of the subcomplex from free ligand rather than under saturation conditions, the numbers of molecules bound to the transacetylase are not necessarily saturation values. The possibility also exists that a few binding sites on the transacetylase were impaired during its isolation and purification. In view of these considerations and the fact that the transacetylase consists of 24 apparently identical polypeptide chains, we interpret the binding data as indicating Although the transacetylase has the potential to bind 24 pyruvate dehydrogenase dimers and 24 flavoprotein dimers, the results of the reconstitution experiments indicate that the transacetylase can accommodate a total of only 12 pyruvate dehydrogenase dimers and six flavoprotein dimers and that this stoichiometry, which is the same as that of the native pyruvate dehydrogenase complex, produces maximum activity. Because enzymatic function requires a particular spatial arrangement of reacting groups, it is likely that attachment of the 12 pyruvate dehydrogenase dimers and six flavoprotein dimers to the transacetylase follows a definite pattern. Electron microscopic studies (16) indicate that the pyruvate dehydrogenase molecules in the native complex are located near the 2-fold positions (i.e., on the edges) of the transacetylase cube and that the flavoprotein molecules are located at the fourfold positions (i.e., in the faces). Apparently, the "excess" molecules of either ligand bound to the transacetylase lie close-to its surface, since the transacetylase-pyruvate dehydrogenase and transacetylase-flavoprotein subcomplexes have essentially the same (Fig. SB) . In order for a pyruvate dehydrogenase dimer to bind on an edge of the cube, "excess" flavoprotein must be displaced from the corresponding face.
An arrangement consisting of 12 pyruvate dehydrogenase dimers symmetrically distributed along the 12 edges of the transacetylase cube and six flavoprotein dimers distributed in the six faces of the cube (Fig. SC) shows little steric hindrance, if any, between the bound ligands, and this arrangement of ligands apparently precludes, by steric hindrance, binding of additional pyruvate dehydrogenase or flavoprotein to the transacetylase. This structural model suggests a possible explanation of the observation (Fig. 2) that of the six flavoprotein dimers that bind to the transacetylase-pyruvate dehydrogenase subcomplex, the initial flavoprotein dimers produce proportionally greater NAD reduction activity than do subsequent flavoprotein dimers. The 24 chains comprising the transacetylase appear to be organized into eight morphological units, each composed of three chains (2) . If a flavoprotein dimer binds to diagonally related morphological units on a face of the transacetylase cube (Fig. SC) (Fig. 3) .
Since binding of pyruvate dehydrogenase in excess of 12 dimers or of flavoprotein in excess of six dimers reduces the activity of the pyruvate dehydrogenase complex, it seems likely that the amount of pyruvate dehydrogenase and flavoprotein synthesized in vivo is regulated. It should be noted in this connection that the structural genes for pyruvate dehydrogenase and dihydrolipoyl transacetylase are closely linked on the E. coli chromosome, and that biosynthesis of the complex begins with the biosynthesis of the pyruvate dehydrogenase component (17) . It appears that there is only one gene controlling the synthesis of dihydrolipoyl dehydrogenase for both the pyruvate and a-ketoglutarate dehydrogenase complexes (18) 
